Brief: Biosynex's Holding In Novacyt On A Voting And Capital Basis Was 3.0012% As At 10th Of February

Biosynex SA

15/02/2022 16:06

Feb 15 (Reuters) - Novacyt SA  ALNOV.PA :
    * WAS NOTIFIED BY BIOSYNEX SA ON 14 FEBRUARY 2022 THAT, AS
AT 10
FEBRUARY 2022, BIOSYNEX'S HOLDING IN COMPANY ON A VOTING AND
CAPITAL BASIS IS 3.0012% (2,119,627 SHARES)

Source text for Eikon:  ID:nRSO7763Ba 
Further company coverage:  ALNOV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))